253 related articles for article (PubMed ID: 16148455)
21. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
[TBL] [Abstract][Full Text] [Related]
22. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
23. Effects of acute smoked marijuana on complex cognitive performance.
Hart CL; van Gorp W; Haney M; Foltin RW; Fischman MW
Neuropsychopharmacology; 2001 Nov; 25(5):757-65. PubMed ID: 11682259
[TBL] [Abstract][Full Text] [Related]
24. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
[TBL] [Abstract][Full Text] [Related]
25. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
[TBL] [Abstract][Full Text] [Related]
27. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD
J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496
[TBL] [Abstract][Full Text] [Related]
28. A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood.
Manning B; Hayley AC; Catchlove S; Stough C; Downey LA
Eur Neuropsychopharmacol; 2024 May; 82():35-43. PubMed ID: 38490083
[TBL] [Abstract][Full Text] [Related]
29. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
[TBL] [Abstract][Full Text] [Related]
30. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
31. The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.
Sugarman DE; Poling J; Sofuoglu M
Pharmacol Biochem Behav; 2011 Mar; 98(1):94-100. PubMed ID: 21176784
[TBL] [Abstract][Full Text] [Related]
32. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.
Heishman SJ; Huestis MA; Henningfield JE; Cone EJ
Pharmacol Biochem Behav; 1990 Nov; 37(3):561-5. PubMed ID: 1965045
[TBL] [Abstract][Full Text] [Related]
33. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
Brady KT; Balster RL
Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
[TBL] [Abstract][Full Text] [Related]
34. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
Haney M
Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
[TBL] [Abstract][Full Text] [Related]
36. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
[TBL] [Abstract][Full Text] [Related]
37. Antinociceptive, subjective and behavioral effects of smoked marijuana in humans.
Greenwald MK; Stitzer ML
Drug Alcohol Depend; 2000 Jun; 59(3):261-75. PubMed ID: 10812286
[TBL] [Abstract][Full Text] [Related]
38. Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing.
Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
Exp Clin Psychopharmacol; 2018 Dec; 26(6):582-598. PubMed ID: 30138003
[TBL] [Abstract][Full Text] [Related]
39. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
40. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.
Nicholson AN; Turner C; Stone BM; Robson PJ
J Clin Psychopharmacol; 2004 Jun; 24(3):305-13. PubMed ID: 15118485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]